Hormone Therapy Global Market Report 2025

Description

Hormone therapy is a form of treatment aimed at modifying, suppressing, or increasing specific hormones within the body. This therapeutic approach is employed to address hormonal imbalances, such as hypothyroidism and other related conditions.

Key categories of hormone therapy include estrogen hormone replacement, growth hormone replacement, thyroid hormone replacement, and testosterone replacement. Estrogen hormone replacement therapy involves the administration of estrogen to elevate the body's estrogen levels. This treatment is delivered through various routes, including oral and parenteral methods. It finds application in conditions such as menopause, hypothyroidism, and growth hormone deficiency. Distribution channels for hormone therapy encompass hospital pharmacies, retail pharmacies, and online pharmacies.

The hormone therapy market research report is one of a series of new reports from The Business Research Company that provides hormone therapy market statistics, including hormone therapy industry global market size, regional shares, competitors with a hormone therapy market share, detailed hormone therapy market segments, market trends and opportunities, and any further data you may need to thrive in the hormone therapy industry. This hormone therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hormone therapy market size has grown strongly in recent years. It will grow from $19.7 billion in 2024 to $21.1 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to medical advancements, women's health revolution, increased awareness and education, clinical research and development, shifting healthcare practices.

The hormone therapy market size is expected to see strong growth in the next few years. It will grow to $28.46 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to personalized medicine approach, aging population dynamics, shift in women's health approaches, focus on wellness and longevity, regulatory adaptations. Major trends in the forecast period include regulatory changes and guidelines, changing lifestyles and stress, research and development, expanding awareness and education.

The growth of the hormone therapy market is significantly fueled by a surge in the incidences of hormone imbalance disorders. Hormone imbalance occurs when the body produces an excess or insufficient amount of a hormone, leading to various disorders such as hypothyroidism, hypogonadism, and growth hormone deficiency. Hormone therapies, including estrogen replacement, testosterone replacement, and insulin therapy, are employed to address these disorders. A 2022 report by London Medical Laboratory revealed an anticipated 19% increase in significant hormone imbalances compared to two years prior. Consequently, the rising prevalence of hormone imbalance disorders is expected to propel the hormone therapy market.

The growing number of elderly individuals is anticipated to drive the expansion of the hormone therapy market in the coming years. Elderly individuals are those in the later stages of life, often associated with the older population or seniors. Hormone therapy for the elderly, especially regarding age-related health issues, aims to rectify hormonal imbalances and address specific conditions linked to aging. For example, in July 2024, the UK Parliament, a UK-based governmental organization, projected that the population of the UK would reach 70 million by 2026. Furthermore, the population is aging, with 19% of individuals aged 65 or older in 2022, a figure expected to increase to 27% by 2072. Thus, the rising number of elderly individuals is propelling the growth of the hormone therapy market.

Leading companies in the hormone therapy market are focusing on innovative solutions, such as direct-to-consumer telehealth models, to improve accessibility and convenience for patients. The direct-to-consumer telehealth model for hormone therapy is a healthcare system that enables patients to access hormone therapy remotely, without needing traditional in-person consultations. For example, in September 2023, LifeMD, a US-based telehealth company, partnered with ASCEND Therapeutics, a US-based pharmaceutical company, to launch an integrated direct-to-consumer telehealth model for hormone therapy, focusing on EstroGel (estradiol gel) to treat menopausal symptoms. This collaboration allows patients to utilize LifeMD's telehealth services directly through the EstroGel website, where they can consult with licensed healthcare providers who can prescribe the medication and arrange home delivery. By simplifying access and addressing barriers such as long wait times, this initiative aims to improve health outcomes for women seeking menopause treatment.

Companies in the hormone therapy market are adopting strategic partnerships to commercialize hormone therapy in North Africa and the Middle East. Strategic partnerships involve companies leveraging their strengths and resources to achieve shared goals. For instance, in October 2023, Cosmo Pharmaceuticals N.V., an Ireland-based pharmaceutical manufacturer of hormonal drugs, announced a strategic agreement with Hikma Pharmaceuticals PLC. Under this deal, Hikma will receive the exclusive rights to register and market Winlevi in 17 countries across the Middle East and North Africa (MENA) region from Cassiopea, a subsidiary of Cosmo. In return, Cassiopea will receive an initial payment of USD 750,000, along with future regulatory and commercial milestone payments. Cassiopea will remain the sole supplier of the product, with pricing based on net sales. Hikma Pharmaceuticals PLC is a UK-based pharmaceutical company.

In July 2022, Grunenthal Group, a German pharmaceutical company, acquired the testosterone treatment Nebido from Bayer AG for approximately $547.4 million. This strategic move is part of Grunenthal's ongoing acquisition strategy, which includes global rights to Qutenza, rights to ex-Japanese company Zomig, global rights to ex-US company Vimovo, and European rights to Crestor and Nexium. Bayer AG, a German pharmaceutical company specializing in hormone therapy and treatments, was the seller in this acquisition.

Major companies operating in the hormone therapy market include Abbott Laboratories, Bayer AG, Eli Lilly and Company, F. Hoffmann-La Roche, Merck KGaA, Mylan NV, Novartis AG, Novo Nordisk AS, Pfizer Inc., Abbvie Inc., Teva Pharmaceutical Industries Ltd., Perrigo Company Plc., Cipla Inc., Lupin Limited, Sun Pharmaceuticals Industries Ltd., Hikma Pharmaceuticals PLC., Johnsons & Johnsons Services Inc., Boehringer Ingelheim International GmbH, Sanofi S.A., AstraZeneca plc, TherapeuticsMD Inc., Amgen Inc., Genentech Inc., Dr. Reddy's Laboratories Ltd, Allergan PLC, GlaxoSmithKline plc, Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., Daiichi Sankyo Company Limited

North America was the largest region in the hormone therapy market in 2024. The regions covered in the hormone therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the hormone therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hormone therapy market includes revenues earned by entities by providing hormone therapies such as insulin therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hormone Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hormone therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hormone therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hormone therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Therapy: Estrogen Hormone Replacement; Growth Hormone Replacement; Thyroid Hormone Replacement; Testosterone Replacement
2) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration
3) By Indication: Menopause; Hypothyroidism; Growth Hormone Deficiency; Other Indications
4) By Distribution Channel: Hospitals Pharmacies; Retail Pharmacies And Stores; Online Pharmacies
Subsegments:
1) By Estrogen Hormone Replacement: Systemic Estrogen Therapy; Local Estrogen Therapy; Combination Estrogen-Progestin Therapy
2) By Growth Hormone Replacement: Recombinant Growth Hormones; Synthetic Growth Hormones
3) By Thyroid Hormone Replacement: Levothyroxine; Liothyronine; Natural Desiccated Thyroid
4) By Testosterone Replacement: Injectable Testosterone; Transdermal Testosterone; Oral Testosterone; Pellets
Companies Mentioned: Abbott Laboratories; Bayer AG; Eli Lilly and Company; F. Hoffmann-La Roche; Merck KGaA
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r23440

1. Executive Summary

2. Hormone Therapy Market Characteristics

3. Hormone Therapy Market Trends And Strategies

4. Hormone Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Hormone Therapy Growth Analysis And Strategic Analysis Framework

5.1. Global Hormone Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Hormone Therapy Market Growth Rate Analysis
5.4. Global Hormone Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Hormone Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Hormone Therapy Total Addressable Market (TAM)

6. Hormone Therapy Market Segmentation

6.1. Global Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Estrogen Hormone Replacement
Growth Hormone Replacement
Thyroid Hormone Replacement
Testosterone Replacement
6.2. Global Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Parenteral
Other Routes of Administration
6.3. Global Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Menopause
Hypothyroidism
Growth Hormone Deficiency
Other Indications
6.4. Global Hormone Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals Pharmacies
Retail Pharmacies And Stores
Online Pharmacies
6.5. Global Hormone Therapy Market, Sub-Segmentation Of Estrogen Hormone Replacement, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Systemic Estrogen Therapy
Local Estrogen Therapy
Combination Estrogen-Progestin Therapy
6.6. Global Hormone Therapy Market, Sub-Segmentation Of Growth Hormone Replacement, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Recombinant Growth Hormones
Synthetic Growth Hormones
6.7. Global Hormone Therapy Market, Sub-Segmentation Of Thyroid Hormone Replacement, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Levothyroxine
Liothyronine
Natural Desiccated Thyroid
6.8. Global Hormone Therapy Market, Sub-Segmentation Of Testosterone Replacement, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Injectable Testosterone
Transdermal Testosterone
Oral Testosterone
Pellets

7. Hormone Therapy Market Regional And Country Analysis

7.1. Global Hormone Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Hormone Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hormone Therapy Market

8.1. Asia-Pacific Hormone Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hormone Therapy Market

9.1. China Hormone Therapy Market Overview
9.2. China Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hormone Therapy Market

10.1. India Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hormone Therapy Market

11.1. Japan Hormone Therapy Market Overview
11.2. Japan Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hormone Therapy Market

12.1. Australia Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hormone Therapy Market

13.1. Indonesia Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hormone Therapy Market

14.1. South Korea Hormone Therapy Market Overview
14.2. South Korea Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hormone Therapy Market

15.1. Western Europe Hormone Therapy Market Overview
15.2. Western Europe Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hormone Therapy Market

16.1. UK Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hormone Therapy Market

17.1. Germany Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hormone Therapy Market

18.1. France Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hormone Therapy Market

19.1. Italy Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hormone Therapy Market

20.1. Spain Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hormone Therapy Market

21.1. Eastern Europe Hormone Therapy Market Overview
21.2. Eastern Europe Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hormone Therapy Market

22.1. Russia Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hormone Therapy Market

23.1. North America Hormone Therapy Market Overview
23.2. North America Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hormone Therapy Market

24.1. USA Hormone Therapy Market Overview
24.2. USA Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hormone Therapy Market

25.1. Canada Hormone Therapy Market Overview
25.2. Canada Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hormone Therapy Market

26.1. South America Hormone Therapy Market Overview
26.2. South America Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hormone Therapy Market

27.1. Brazil Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hormone Therapy Market

28.1. Middle East Hormone Therapy Market Overview
28.2. Middle East Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hormone Therapy Market

29.1. Africa Hormone Therapy Market Overview
29.2. Africa Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hormone Therapy Market Competitive Landscape And Company Profiles

30.1. Hormone Therapy Market Competitive Landscape
30.2. Hormone Therapy Market Company Profiles
- 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. F. Hoffmann-La Roche Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

31. Hormone Therapy Market Other Major And Innovative Companies

31.1. Mylan NV
31.2. Novartis AG
31.3. Novo Nordisk AS
31.4. Pfizer Inc.
31.5. Abbvie Inc.
31.6. Teva Pharmaceutical Industries Ltd.
31.7. Perrigo Company Plc.
31.8. Cipla Inc.
31.9. Lupin Limited
31.10. Sun Pharmaceuticals Industries Ltd.
31.11. Hikma Pharmaceuticals PLC.
31.12. Johnsons & Johnsons Services Inc.
31.13. Boehringer Ingelheim International GmbH
31.14. Sanofi S.A.
31.15. AstraZeneca plc

32. Global Hormone Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hormone Therapy Market

34. Recent Developments In The Hormone Therapy Market

35. Hormone Therapy Market High Potential Countries, Segments and Strategies

35.1 Hormone Therapy Market In 2029 - Countries Offering Most New Opportunities
35.2 Hormone Therapy Market In 2029 - Segments Offering Most New Opportunities
35.3 Hormone Therapy Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer